Cardinal Health Stock News

Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 Aristocrats raising payouts in 2025 and an average growth rate of 5.14%, signaling continued income reliability. My 'Promising Aristocrats' list, focused on undervaluation and projected total return...

DUBLIN, Ohio , Aug. 15, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on October 15, 2025 to shareholders of record at the close of business on October 1, 2025.

Sprawling healthcare company Cardinal Health (CAH -7.08%) reported its latest quarterly results and announced a sizable new acquisition Tuesday morning. The market didn't take these news items well, however, and in late-session trading, it was pushing the company's share price down by nearly 7%.

Cardinal Health's multi-specialty management services organization (MSO), The Specialty Alliance, plans to acquire urology MSO Solaris Health. Cardinal Health will enable the acquisition by providing about $1.9 billion in cash to The Specialty Alliance and will own about 75% of The Specialty Alliance after the acquisition of Solaris Health, Cardinal Health said in a Tuesday (Aug.

U.S. equities gained at midday after the latest report on consumer inflation came in lower than expected, boosting hopes of a Federal Reserve rate cut. The Nasdaq and S&P 500 traded at record highs, and the Dow Jones Industrial Average was up as well.

Cardinal Health, Inc. (NYSE:CAH ) Q4 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Aaron E. Alt - Chief Financial Officer Jason M.

The company will acquire Solaris Health, a urology management services organization, for around $1.9 billion in cash.

Fourth quarter revenue was relatively flat at $60.2 billion; revenue increased 21% excluding the impact of a previously communicated contract expiration Fourth quarter GAAP1 operating earnings were $428 million and GAAP diluted EPS was $1.00 Fourth quarter non-GAAP operating earnings increased 19% to $719 million and non-GAAP diluted EPS increased 13% to $2.08 Fiscal Year 2025 adjusted free cas...